Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
HIV Market Forecast
Interactive Model
Published: June 2009
Pages: For full details, please email keithw@cmsinfo.com
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 0.00 Buy Now!
Research from: Datamonitor
Sector: Indication Areas
Introduction
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an increase in HIV prevalence, a series of patent expiries will impact branded sales from 2011.
Reasons to Purchase
*Understand the changing market dynamics of HIV drugs, success factors for leading brands and the commercial potential of late stage pipeline products
*Assess the impact of events such as patent expiries and new product launches on individual brands and the overall antiretroviral market.
*Obtain full global, country, class and product-specific forecasts of currently marketed and pipeline antiretrovirals from 2008 to 2018.
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an increase in HIV prevalence, a series of patent expiries will impact branded sales from 2011.
Reasons to Purchase
*Understand the changing market dynamics of HIV drugs, success factors for leading brands and the commercial potential of late stage pipeline products
*Assess the impact of events such as patent expiries and new product launches on individual brands and the overall antiretroviral market.
*Obtain full global, country, class and product-specific forecasts of currently marketed and pipeline antiretrovirals from 2008 to 2018.